Literature DB >> 10216119

Macronutrient preference, dietary intake, and substrate oxidation among stable cirrhotic patients.

H I Davidson1, R Richardson, D Sutherland, O J Garden.   

Abstract

Anorexia in liver disease is common; however, its association with aberrant metabolism and the type of cirrhosis has not been considered. Dietary intake, nutritional status, fasting substrate oxidation, and macronutrient preference were examined in controls (n = 18) and 65 patients with hepatocellular (n = 31) or biliary cirrhosis (n = 34). Energy intakes were lowest in hepatocellular patients (controls: 9.0 +/- 0.48 megajoules/day compared with biliary: 7.0 +/- 0.40 MJ/day, P <.05; controls compared with hepatocellular 6.5 +/- 0.39 megajoules/day, P <.01). Triceps skinfold was lower only in hepatocellular patients (controls: 109 +/- 9.2% compared with hepatocellular 79 +/- 5.6%, P <.05). The fasting rate of lipid oxidation was elevated in hepatocellular patients when compared with controls and biliary patients (controls: 40.9 +/- 15.1 mg/min compared with hepatocellular 62.8 +/- 16.8 mg/min, P <.001, and biliary : 45.5 +/- 17.0 mg/min compared with hepatocellular, P <.001). Control subjects exhibited a greater preference for the high fat, moderate carbohydrate food (controls: median 7.0 IQR 2.0 compared with biliary: median 5.0 interquartile range [IQR] 4.7, P <.01) (controls compared with hepatocellular: median 6.0 IQR 4.0, P <.01). Cirrhotic patients' spontaneous dietary intake is lower than that of controls and recommended intakes. Although macronutrient preference ratings were different within cirrhotic patient groups it remains unclear whether associated nutrient deficits are metabolically driven and dictated by primary cause.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216119     DOI: 10.1002/hep.510290531

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

Review 1.  The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists.

Authors:  Ponni V Perumalswami; Thomas D Schiano
Journal:  Dig Dis Sci       Date:  2011-03-18       Impact factor: 3.199

Review 2.  Gastrointestinal dysfunction in liver cirrhosis.

Authors:  Evangelos Kalaitzakis
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

3.  Fasting and postprandial plasma ghrelin levels are decreased in patients with liver failure previous to liver transplantation.

Authors:  Maria Teresa Diz-Lois; Jesús Garcia-Buela; Francisco Suarez; Susana Sangiao-Alvarellos; Ovidio Vidal; Fernando Cordido
Journal:  Endocrine       Date:  2009-04-11       Impact factor: 3.633

Review 4.  Sarcopenia and liver transplant: The relevance of too little muscle mass.

Authors:  Eric R Kallwitz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

5.  Impact of Bacterial Translocation on Sarcopenia in Patients with Decompensated Cirrhosis.

Authors:  Cynthia Tsien; Lilia Antonova; Jose Such; Irma Garcia-Martinez; Florence Wong
Journal:  Nutrients       Date:  2019-10-05       Impact factor: 5.717

Review 6.  Nutritional support in chronic liver disease and cirrhotics.

Authors:  Ravi Shergill; Wajahat Syed; Syed Ali Rizvi; Ikjot Singh
Journal:  World J Hepatol       Date:  2018-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.